Genetic Determination of Susceptibility to Estrogen-Induced Mammary Cancer in the ACI Rat
Open Access
- 1 December 2004
- journal article
- Published by Oxford University Press (OUP) in Genetics
- Vol. 168 (4) , 2113-2125
- https://doi.org/10.1534/genetics.104.033878
Abstract
Hormonal, genetic, and environmental factors play major roles in the complex etiology of breast cancer. When treated continuously with 17β-estradiol (E2), the ACI rat exhibits a genetically conferred propensity to develop mammary cancer. The susceptibility of the ACI rat to E2-induced mammary cancer appears to segregate as an incompletely dominant trait in crosses to the resistant Copenhagen (COP) strain. In both (ACI × COP)F2 and (COP × ACI)F2 populations, we find strong evidence for a major genetic determinant of susceptibility to E2-induced mammary cancer on distal rat chromosome 5. Our data are most consistent with a model in which the ACI allele of this locus, termed Emca1 (estrogen-induced mammary cancer 1), acts in an incompletely dominant manner to increase both tumor incidence and tumor multiplicity as well as to reduce tumor latency in these populations. We also find evidence suggestive of a second locus, Emca2, on chromosome 18 in the (ACI × COP)F2 population. The ACI allele of Emca2 acts in a dominant manner to increase incidence and decrease latency. Together, Emca1 and Emca2 act independently to modify susceptibility to E2-induced mammary cancer.Keywords
This publication has 64 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Three Loci Modify Growth of a Transgene-Induced Mammary Tumor: Suppression of Proliferation Associated with Decreased Microvessel DensityGenomics, 2001
- AP-1 blockade inhibits the growth of normal and malignant breast cellsOncogene, 2001
- Patterns of chromosomal imbalances in invasive breast cancerInternational Journal of Cancer, 2000
- cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotypeOncogene, 1999
- Interacting Quantitative Trait Loci Control Phenotypic Variation in Murine Estradiol-Regulated ResponsesEndocrinology, 1999
- Assignment1 of the cyclin-dependent kinase inhibitor genes Cdkn2a and Cdkn2b to rat chromosome bands 5q32→q34 and 5q31→q33, respectively by fluorescence in situ hybridization, using small PCR-generated probesCytogenetic and Genome Research, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regionsInternational Journal of Cancer, 1995
- Genetic alterations in breast cancerGenes, Chromosomes and Cancer, 1995